Which Treatment Mechanism Suits Your Weight Goals?
Mounjaro V Wegovy: UK Stock Availability Comparison
UK availability has been a genuine concern for weight management patients, particularly with historical Wegovy supply shortages. At EverydayMeds, we maintain reliable stock of both Mounjaro and Wegovy through established partnerships with Novo Nordisk and Eli Lilly. Our GPhC-registered pharmacy (#9012878) processes orders within 24-72 hours, ensuring you can start your prescribed treatment without delay. Unlike some providers who operate waiting lists, we confirm stock availability before taking your order.
Both treatments require the same clinical assessment process, but the choice between Mounjaro v Wegovy often depends on your medical history and prescriber recommendation. Wegovy offers practical storage advantages with 6 weeks room temperature tolerance compared to Mounjaro's 21 days, making it more travel-friendly for UK patients. Our clinical team reviews each application individually to determine which prescription-only medicine aligns with your weight management goals and any existing health conditions.
Wegovy Pricing Structure With UK Discount Codes
Our Wegovy pricing reflects the complete dose escalation journey, starting with 0.25mg pens at £79.99 and progressing to maintenance 2.4mg pens at £209.99. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. The Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first 8 weeks of treatment in one convenient order. Progress Duo (0.5mg & 1mg) follows at £189.99 for weeks 5-12 of your escalation schedule.
For patients preferring longer-term supply security, our Ultimate Stability Trio provides three months of maintenance 2.4mg pens for £649.99. This eliminates the need for monthly reordering once you've reached your optimal dose. Mounjaro pricing follows a different structure due to its distinct manufacturing and licensing costs, though both treatments are available through the same streamlined ordering process at EverydayMeds.
Clinical Evidence: Mounjaro V Wegovy Trial Data
Wegovy demonstrated significant results in the STEP clinical programme, with patients achieving approximately 15% average weight loss at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, highlighting potential heart health benefits beyond weight management. These results reflect carefully controlled trial conditions with intensive lifestyle support.
Mounjaro's SURMOUNT trials evaluated tirzepatide's dual-action mechanism targeting both GIP and GLP-1 receptors simultaneously. However, comparing trial results directly between Mounjaro v Wegovy isn't clinically meaningful due to different study designs, patient populations, and measurement endpoints. Both treatments require prescription-only medicine status and clinical supervision throughout your weight management journey.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for appetite regulation. After injection, it works on brain appetite centres to reduce hunger signals whilst promoting feelings of fullness after smaller meal portions. The once-weekly FlexTouch pen delivers precise doses subcutaneously, typically in your abdomen, thigh, or upper arm. Unlike Mounjaro's dual-action approach, Wegovy focuses specifically on GLP-1 pathways that control satiety and gastric emptying. This targeted mechanism may help reduce food cravings and support portion control when combined with structured dietary changes. The treatment works gradually, which is why the mandatory 16-week dose escalation from 0.25mg to 2.4mg allows your body to adapt progressively.
EverydayMeds Ordering Process: Assessment To Delivery
Our streamlined process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Qualified prescribers review your application within standard 3 working days (or 24 hours with express service) to determine suitability for either Mounjaro or Wegovy. Once approved, we dispatch your prescription-only medicine via next-day delivery using temperature-controlled packaging to maintain cold-chain integrity. Our pharmacy team coordinates with DPD or Royal Mail to ensure someone's available for delivery, given the refrigerated storage requirements. You'll receive tracking information and injection guidance materials with your first order. The entire process from assessment to doorstep typically takes 4-5 working days, ensuring you can start treatment promptly without clinic appointments or lengthy waiting periods.
Storage Requirements And Practical Considerations
Both Mounjaro and Wegovy require refrigerated storage at 2-8°C before first use, but Wegovy offers superior room temperature tolerance at 6 weeks versus Mounjaro's 21 days once removed from the fridge. This storage advantage makes Wegovy more practical for UK patients who travel frequently for work or holidays. Each FlexTouch pen contains 4 doses, administered weekly on the same day each week. The mandatory dose escalation cannot be skipped—you must progress through 0.25mg, 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose. Our pharmacy includes detailed injection instructions and disposal guidance with every order. Both treatments work optimally alongside a reduced-calorie diet and increased physical activity, as outlined in their MHRA licensing conditions.
Mounjaro V Wegovy: UK Prescribing Preferences
UK prescribers increasingly consider both options when evaluating weight management treatments, particularly for patients with different metabolic profiles or previous GLP-1 experience. Some clinicians prefer starting with Wegovy due to its established NICE TA875 recommendation and longer real-world safety data, whilst others favour Mounjaro's dual-receptor approach for patients who haven't responded optimally to single-action treatments. The choice often depends on your diabetes status, cardiovascular risk factors, and gastrointestinal tolerance patterns.
Geographic availability across the UK remains consistent for both treatments through our Manchester-based distribution centre, serving Scotland, Wales, Northern Ireland, and all English regions equally. Both Mounjaro and Wegovy are available from EverydayMeds—your prescriber can help determine which aligns best with your clinical profile and lifestyle requirements. This eliminates the guesswork of choosing between treatments without professional medical guidance.
Order Your Prescribed Treatment Today
Both Wegovy and Mounjaro remain in stock with Reliable UK availability through our established supply partnerships. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 for immediate savings. Complete your clinical assessment at https://everydaymeds.co.uk/collections/wegovy to begin the prescriber review process. Our qualified medical team will determine the most appropriate treatment based on your individual circumstances and medical history. Start your weight management journey today with confidence in our reliable UK supply chain and expert clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
